Lemonade Reports Strong Q4 2025 Results with Accelerating Growth & Path to Profitability
Summary
Lemonade, Inc. announced robust fourth-quarter and full-year 2025 financial results, showcasing accelerated growth in In Force Premium and significant improvements in profitability metrics, alongside positive guidance for 2026 and a reiterated path to full-year Adjusted EBITDA profitability in 2027.
Key Events
-
Strong Q4 2025 Financial Performance
Lemonade reported Q4 2025 In Force Premium of $1.24 billion (up 31% YoY), revenue of $228 million (up 53% YoY), and gross profit of $111 million (up 73% YoY). Net loss significantly improved to ($22) million, and Adjusted EBITDA loss narrowed to ($5) million.
-
Accelerated Growth & Underwriting Excellence
The company achieved its ninth consecutive quarter of IFP growth acceleration and an 11 percentage point year-over-year improvement in the Gross Loss Ratio to 52%, reflecting enhanced underwriting performance.
-
Reiterated Path to Profitability
Lemonade reiterated its expectation for positive Adjusted EBITDA in the fourth quarter of 2026, with 2027 projected to be its first full year of Adjusted EBITDA profitability.
-
Positive 2026 Guidance
The company provided 2026 guidance, anticipating 32% IFP growth and a greater than 50% improvement in its full-year Adjusted EBITDA loss compared to 2025.
Analysis
Lemonade, Inc. delivered a robust fourth quarter and full-year 2025, demonstrating significant progress across key financial and operational metrics. The company achieved its ninth consecutive quarter of In Force Premium (IFP) growth acceleration, alongside substantial improvements in gross profit and a narrowed Adjusted EBITDA loss. The strong performance in core product lines like Pet, Car, and Europe, driven by AI and automation, underpins the company's strategy for sustained growth and operating leverage. The reiterated guidance for positive Adjusted EBITDA in Q4 2026 and full-year 2027 profitability provides a clear and positive outlook for investors, signaling a strong trajectory towards financial health.
At the time of this filing, LMND was trading at $73.50 on NYSE in the Finance sector, with a market capitalization of approximately $4.9B. The 52-week trading range was $24.31 to $99.90. This filing was assessed with positive market sentiment and an importance score of 9 out of 10.